Fair Allocation of Scarce Therapies for Coronavirus Disease 2019 (COVID-19)

The US Food and Drug Administration (FDA) has issued emergency use authorizations (EUAs) for monoclonal antibodies (mAbs) for nonhospitalized patients with mild or moderate coronavirus disease 2019 (COVID-19) disease and for individuals exposed to COVID-19 as postexposure prophylaxis. EUAs for oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Persad, Govind, Peek, Monica E, Shah, Seema K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Viewpoints Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807190/
https://www.ncbi.nlm.nih.gov/pubmed/34922352
http://dx.doi.org/10.1093/cid/ciab1039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807190/
https://www.ncbi.nlm.nih.gov/pubmed/34922352
http://dx.doi.org/10.1093/cid/ciab1039

Ejemplares similares